The iBinom platform applies efficient algorithms and unique machine learning technology to analyze genome information for inherited disease diagnostics, tumor profiling, and drug response biomarker discovery studies. It uses Amazon EC2 and special design of medical reports to simplify and expedite the diagnostic process, providing medical geneticists with clinical reports within 1-2 hours instead of 1-2 days. With iBinom, physicians and geneticists can improve their analysis through precision, sensitivity, and specificity, ultimately helping seriously ill patients by solving the diagnostic and treatment odyssey.